Skip to main content

Table 4 Regression analysis of the independent effect of CKD on outcomes

From: Cardiovascular outcomes following percutaneous coronary intervention with drug-eluting balloons in chronic kidney disease: a retrospective analysis

Variable

Coefficient

CI 95%

SD

OR

OR CI 95%

RR

RR CI 95%

P value

MACE-- 1st year

0.7

0.02 – 1.5

0.4

2.1

1.0 - 4.3

1.8

0.9 – 3.3

< 0.05

MI- 1st year

1.6

0.5 – 2.6

0.5

4.8

1.7 – 14.2

3.6

1.4 – 9.1

< 0.005

Death- 1st year

1.1

(−0.2) - 2.4

0.7

3

0.9 - 11.1

2.6

0.8 – 8.3

0.1

Death- 2nd year

0.9

0.03 - 1.9

0.5

2.6

3.6 - 6.7

2.2

0.9 - 5

< 0.05

Cardiac death- 1st year

41.3

(−33,096) - 33,178.9

16,845.8

0

0-inf

0

0-inf

1

Cardiac death- 1st + 2nd years

0.8

(−1.3) - 3.0

1.1

2.3

0.3 - 20.0

1.9

0.3 – 12.5

0.5

Hospitalizations- 1st year

0.7

0.2 - 1.2

0.3

    

0.01

Hospitalizations- 1st + 2nd year

1.1

0.4 - 1.8

0.4

    

< 0.05

Cardiac hospitalizations- 1st year

0.5

0.1 - 0.8

0.2

    

< 0.01

Cardiac hospitalizations- 1st + 2nd years

0.7

0.3 - 1.2

0.2

    

0.001

1st year catheterization

0.01

(−0.2) - 0.2

0.08

    

0.9

TLR

0.6

(−0.2) - 1.4

0.4

1.8

0.8 - 4

1.6

0.8 – 3.4

0.2

Additional DEB

(−1.2)

(−2.9) - 0.5

0.9

0.3

0.1 - 1.6

0.3

0.1 – 1.6

0.2

Stroke- 1st year

0.3

(−2.0) - 2.7

1.2

1.4

0.1 – 14.3

1.4

0.1 – 14.2

0.8

Hemorrhages- 1st year

0.02

(−0.05) -0.09

0.04

    

0.6

  1. DEB Drug eluting balloon, MACE Major adverse cardiac events, MI Myocardial infraction, TLR Target lesion revascularization